New Minimally Invasive Benign Prostatic Hyperplasia Treatments: Urocross and Innovations
By Shawn M. McGee, M.D. | Medically Reviewed by Christopher W. Boelter, MD |Last updated 2026-06-03 Benign prostatic hyperplasia (BPH) affects nearly 50% of men over 50 and up to 80% of men over 70. Symptoms such as frequent urination, weak stream, and nocturia disrupt sleep, work, and quality of life. For decades, the standard surgical treatment was transurethral […]
New Minimally Invasive Benign Prostatic Hyperplasia Treatments: Urocross and Innovations Read More »